Jarrow Formulas Unveils Fem-Dophilus

Los Angeles, CA, April 12, 2006 – Jarrow Formulas, a pioneer in probiotics since 1987, has unveiled Fem-Dophilus, the only oral probiotic clinically documented to restore and maintain a healthy vaginal flora and reduce the risk of urogenital infections.

Fem-Dophilus features the world's most documented probiotic strains for women's health, Lactobacillus rhamnosus GR-1â„¢ and Lactobacillus reuteri RC-14â„¢ discovered and developed by Drs. Gregor Reid and Andrew Bruce of Urex Biotech, Inc., and is produced and marketed globally by Chr. Hansen, a world leader in probiotics.

Research has confirmed that GR-1â„¢ and RC-14â„¢ taken as an oral supplement colonize and protect the vaginal tract. More than 20 years of research has shown that GR-1 and RC-14 help to restore and maintain the balance of flora important to vaginal health and the health of the urinary tract overall.

“It has been established that women with an unhealthy intestinal microflora profile are at a higher risk of developing urinary and vaginal infections,” says Peilin Guo, MS, RD, Vice President of Functional Foods for Jarrow Formulas. “Fortunately, scientific and clinical studies indicate that external beneficial microflora can colonize the intestinal and vaginal tract, and help maintain the health of the vaginal and urinary tracts. This suggests that the daily ingestion of certain probiotics might provide a natural, safe and effective means in supporting women’s health.”

According to Brian Peeters, Jarrow’s Probiotic Product Manager, “Fem-Dophilus is a great addition to Jarrow Formulas extensive line of high-quality probiotic supplements. It is the only clinically proven vaginal probiotic supplement on the market. We have received very good response to this unique probiotic product from retailers, consumers and practitioners.”

Patented Fem-Dophilus is manufactured at a Good Manufacturing Practices (GMP) pharmaceutical facility under strict quality control to ensure potency and consistency. The probiotic strains in Fem-Dophilus are in a proprietary polysaccharide matrix, which protects the bacteria from stomach acid and enhances probiotic bacteria survival to the lower intestine.
The suggested retail price (SRP) for Jarrow Formulas’ Fem-Dophilus is $23.95 for a bottle of 30 capsules.

Jarrow Formulas is a nutritional supplement formulator and marketer founded in 1977 and incorporated in 1988. The company markets its products throughout the United States and internationally in more than 20 countries in Europe, Asia, Israel and Latin America. The company offers a complete line of nutritional products that includes vitamins, minerals, probiotics, standardized herbal concentrates, amino acids, enzymes and enteral nutrition formulations. Jarrow Formulas, Inc. is active in regulatory affairs, helping to maintain American’s rights to free access to dietary supplements. Its products are manufactured by Jarrow Industries Incorporated, a pharmaceutical quality facility located in Santa Fe Springs, CA. For more information, contact Mark Becker, Director, Advertising/Communications toll free at (800) 726-0886 or access the Jarrow Formulas Web site at www.Jarrow.com.


Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.